The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is a completion axillary dissection in patients with early breast cancer with a positive sentinel node necessary? An NCDB-based trial emulation of ACOSOG Z0011.
 
Yuan Liu
No Relationships to Disclose
 
Lara Schwieger
No Relationships to Disclose
 
Lauren Postlewait
No Relationships to Disclose
 
Sagar Anil Patel
No Relationships to Disclose
 
Mylin Ann Torres
Employment - Emory Healthcare
Stock and Other Ownership Interests - Oncology Analytics
Honoraria - EncoreMed Educationn; EncoreMed Educationn; MJH Life Sciences; MJH Life Sciences; OncLive/MJH Life Sciences; Varian Medical Systems
Consulting or Advisory Role - Oncohealth; Oncology Analytics; Pfizer
Research Funding - Genentech; Pfizer; Pfizer; Pfizer/NCCN (Inst)
Travel, Accommodations, Expenses - BioAscent; BioAscent; Prime Oncology
 
Kevin Kalinsky
Employment - EQRx (I); GRAIL (I)
Stock and Other Ownership Interests - EQRx (I); GRAIL (I)
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Cullinan Oncology; Cullinan Oncology; Daiichi Sankyo/Astra Zeneca; eFFECTOR Therapeutics; Genentech/Roche; immunomedics; Lilly; Menarini Silicon Biosystems; Merck; mersana; Myovant Sciences; Novartis; Oncosec; Prelude Therapeutics; Puma Biotechnology; RayzeBio; RayzeBio; Seagen; Takeda
Research Funding - Ascentage Pharma (Inst); AstraZeneca (Inst); Daichi Sankyo (Inst); Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Seagen (Inst)
Other Relationship - Genentech; Immunomedics
 
Cletus Arciero
No Relationships to Disclose
 
Yixin Chen
No Relationships to Disclose